CSIMarket
 


Axim Biotechnologies Inc   (AXIM)
Other Ticker:  
 

Axim Biotechnologies Inc 's Working Capital Ratio

AXIM's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the third quarter 2023, Working Capital Ratio deteriorated to 0.01 a new company low.

Within Major Pharmaceutical Preparations industry 514 other companies have achieved higher Working Capital Ratio than Axim Biotechnologies Inc in third quarter 2023. While Working Capital Ratio total ranking has improved so far during the III Quarter 2023 to 4888, from total ranking in the second quarter 2023 at 5082.

Explain Working Capital Ratio
How much in Current Assets AXIM´s has?
What is the value of AXIM´s Current Liabilities?


AXIM Working Capital Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Change 35.25 % 208.52 % 44.69 % 29.59 % 98.33 %
Y / Y Current Assets Change -87.32 % -40.22 % -89.11 % -83.67 % -49.16 %
Working Capital Ratio MRQ 0.01 0.01 0.01 0.03 0.08
AXIM's Total Ranking # 4888 # 5082 # 4634 # 4801 # 4969
Seq. Current Liabilities Change -48.86 % 72.01 % 45.4 % 5.74 % 16.66 %
Seq. Current Assets Change -69.74 % 81.94 % -43.7 % -59.1 % 42.68 %



Working Capital Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 515
Healthcare Sector # 1059
Overall Market # 4888


Working Capital Ratio Statistics
High Average Low
1.14 0.35 0.01
(Jun 30 2015)   (Sep 30 2023)




Financial Statements
Axim Biotechnologies Inc 's Current Liabilities $ 4 Millions Visit AXIM's Balance sheet
Axim Biotechnologies Inc 's Current Assets $ 0 Millions Visit AXIM's Balance sheet
Source of AXIM's Sales Visit AXIM's Sales by Geography


Cumulative Axim Biotechnologies Inc 's Working Capital Ratio

AXIM's Working Capital Ratio for the trailling 12 Months

AXIM Working Capital Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities TTM Growth 35.25 % 208.52 % 44.69 % 29.59 % 98.33 %
Y / Y Current Assets TTM Growth -87.32 % -40.22 % -89.11 % -83.67 % -49.16 %
Working Capital Ratio TTM 0.01 0.03 0.04 0.09 0.14
Total Ranking TTM # 3989 # 4200 # 4352 # 4918 # 4647
Seq. Current Liabilities TTM Growth -48.86 % 72.01 % 45.4 % 5.74 % 16.66 %
Seq. Current Assets TTM Growth -69.74 % 81.94 % -43.7 % -59.1 % 42.68 %


On the trailing twelve months basis Due to drop in Current Liabilities in the III Quarter 2023 to $4.28 millions, cumulative Working Capital Ratio decreased to 0.01 below the Axim Biotechnologies Inc average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 499 other companies have achieved higher Working Capital Ratio than Axim Biotechnologies Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2023 from 3700 to 4010.

Explain Working Capital Ratio
How much in Current Assets AXIM´s has?
What is the value of AXIM´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 500
Healthcare Sector # 1044
Within the Market # 4888


trailing twelve months Working Capital Ratio Statistics
High Average Low
0.7 0.33 0.01
(Sep 30 2019)   (Sep 30 2023)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Working Capital RatioSep 30 2023 MRQ Current AssetsSep 30 2023 MRQ Current Liabilities
Skinvisible Inc   0.02 $ 0.053  Millions$ 3.244  Millions
Kaya Holdings Inc  0.02 $ 0.123  Millions$ 7.771  Millions
Novaccess Global Inc   0.01 $ 0.062  Millions$ 7.861  Millions
Axim Biotechnologies Inc   0.01 $ 0.032  Millions$ 4.278  Millions
Cannapharmarx Inc 0.00 $ 0.054  Millions$ 20.229  Millions
Biostax Corp 0.00 $ 0.010  Millions$ 4.212  Millions

Date modified: 2023-11-21T23:05:36+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com